Pfizer is a research-based, global biopharmaceutical company. Co. is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Co. collaborates with healthcare providers, governments and local communities to support and expand access to healthcare around the world. Co. provides vaccines across various ages (infants, adolescents and adults) in pneumococcal disease, meningococcal disease, tick-borne encephalitis and novel coronavirus disease of 2019 (COVID-19). Key products include: Comirnaty/BNT162b2, the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac and Trumenba. We show 57 historical shares outstanding datapoints in our PFE shares outstanding history coverage, used to compute PFE market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing PFE market cap history over the course of time is important for investors
interested in comparing PFE's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of PFE versus a peer is one thing; comparing
PFE market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like PFE can fluctuate over the course of history.
With this page we aim to empower investors researching PFE by allowing them to research the PFE market cap history. |
Free PFE Email Alerts:
Video: The Importance of Market Cap
